SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-020526
Filing Date
2017-10-31
Accepted
2017-10-31 16:11:34
Documents
65
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q adro-10q_20170930.htm 10-Q 2416382
2 EX-31.1 adro-ex311_9.htm EX-31.1 12435
3 EX-31.2 adro-ex312_6.htm EX-31.2 12503
4 EX-32.1 adro-ex321_8.htm EX-32.1 8406
  Complete submission text file 0001564590-17-020526.txt   8097990

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT adro-20170930.xml EX-101.INS 1814226
6 XBRL TAXONOMY EXTENSION SCHEMA adro-20170930.xsd EX-101.SCH 50516
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE adro-20170930_cal.xml EX-101.CAL 58588
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE adro-20170930_def.xml EX-101.DEF 159425
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE adro-20170930_lab.xml EX-101.LAB 433190
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE adro-20170930_pre.xml EX-101.PRE 316657
Mailing Address 740 HEINZ AVENUE BERKELEY CA 94710
Business Address 740 HEINZ AVENUE BERKELEY CA 94710 510-848-4400
ADURO BIOTECH, INC. (Filer) CIK: 0001435049 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37345 | Film No.: 171165840
SIC: 2834 Pharmaceutical Preparations